Market Outlook

By 2035, the U.S. Wireless Patient Monitoring Devices Market is expected to reach approximately USD 42.44 billion, expanding at a CAGR of 13.80% during 2026-2035. The market was valued at USD 11.65 billion in 2025, following historical expansion from USD 6.90 billion in 2021 to USD 10.10 billion in 2024. Values in this report are expressed in USD billions. The market definition covers clinically used wireless monitoring hardware, wearable and patch-based sensors, connected home-monitoring devices, patient-worn telemetry, communication gateways, and device-linked connectivity licenses. It excludes general-purpose wellness wearables without a clinical monitoring use case and excludes standalone telehealth consultation revenue.

The U.S. wireless patient monitoring devices industry is moving from a collection of isolated products into an integrated clinical infrastructure layer. Wireless ECG patches, continuous glucose monitors, connected blood pressure cuffs, pulse oximeters, wearable multiparameter sensors, mobile cardiac telemetry, smart scales, respiratory monitors, fetal and maternal monitoring systems, and in-hospital telemetry devices are increasingly used to extend clinical visibility beyond the bedside. The economic value is not created by wireless transmission alone. Buyers are paying for earlier recognition of deterioration, lower manual documentation burden, shorter inpatient stays, more efficient nurse surveillance, improved chronic disease control, and the ability to manage patients across hospital, ambulatory, post-acute, and home settings.

Demand is supported by the scale of the addressable patient population. Nearly half of U.S. adults have hypertension, approximately 38 million adults have diabetes, and chronic respiratory disease remains a major source of hospitalization and mortality. The U.S. population aged 65 and older reached about 61.2 million in 2024, representing 18.0% of the population, which materially expands the pool of patients requiring longitudinal monitoring. At the same time, the country operates more than 6,100 hospitals with roughly 907,000 staffed beds and more than 35 million annual admissions, creating a large installed base for wireless bedside, transport, telemetry, and enterprise monitoring upgrades.

The historical market accelerated as health systems converted pandemic-era monitoring pilots into permanent clinical programs. Market value increased from USD 6.90 billion in 2021 to USD 7.72 billion in 2022, USD 8.83 billion in 2023, USD 10.10 billion in 2024, and USD 11.65 billion in 2025. Growth was supported by continuous glucose monitoring, ambulatory cardiac diagnostics, Medicare remote physiologic monitoring reimbursement, hospital-at-home programs, networked patient surveillance, and stronger demand for mobile monitoring during intra-hospital transport. From 2026 through 2035, the market will be shaped by a shift from device acquisition toward enterprise monitoring architecture, where sensors, connectivity, analytics, clinical workflow, cybersecurity, and reimbursement support are evaluated as one operating system.

 

Introduction

According to the U.S. Wireless Patient Monitoring Devices Market Report, wireless monitoring has become a core component of decentralized care delivery. The market spans high-acuity hospital telemetry, intermediate-acuity continuous surveillance, ambulatory diagnostic monitoring, chronic disease management, post-discharge observation, and home-based care. These use cases have different purchasing criteria, but all depend on reliable physiologic data acquisition, automatic digital transmission, clinically actionable presentation, and an escalation workflow that does not overwhelm care teams.

The market is structurally attractive because it combines recurring sensors and consumables with durable monitoring hardware, gateways, software-enabled device management, and replacement cycles. Cardiac patches, continuous glucose sensors, pulse oximetry sensors, disposable wearable biosensors, and electrode sets generate repeat revenue. Bedside monitors, central stations, telemetry infrastructure, and mobile gateways support capital or managed-service models. The result is a diversified revenue pool in which established monitoring companies, chronic disease device leaders, digital care platforms, and specialized biosensor innovators compete across different layers of the value chain.

U.S. hospital procurement behavior is becoming more selective. Health systems are no longer satisfied with a device that connects to a dashboard. They expect validated alarm performance, uptime, wireless coexistence, cybersecurity resilience, integration with electronic health records, fleet management, battery-life predictability, infection-control compatibility, and service support across multiple facilities. Large integrated delivery networks increasingly standardize monitoring platforms to reduce training complexity, simplify biomedical engineering support, and improve enterprise data continuity. A product that performs well clinically but creates fragmented workflow or excessive false alerts can lose procurement support despite an attractive acquisition price.

Remote patient monitoring reimbursement adds a second economic engine. Medicare broadly covers remote physiologic monitoring for acute and chronic conditions when an internet-connected medical device digitally uploads data and the provider performs the required setup, supply, and treatment-management components. Medicare payments for remote patient monitoring exceeded USD 500 million in 2024, confirming that connected monitoring has moved beyond a niche pilot category. However, reimbursement growth is accompanied by tighter scrutiny of billing integrity, patient engagement, device utilization, and whether clinical management is actually occurring. This will favor vendors that support compliance-ready workflows instead of maximizing enrollment without measurable care delivery.

The strategic direction through 2035 is a transition from episodic measurements to continuous or near-continuous risk detection. The winning systems will not merely collect blood pressure, heart rate, oxygen saturation, glucose, respiratory rate, temperature, weight, or ECG data. They will prioritize the patients who need intervention, filter non-actionable variation, integrate with clinical communication tools, document response, and show impact on avoidable emergency visits, readmissions, length of stay, and clinician workload. For report buyers, the most important question is therefore not how many connected devices will be sold, but which monitoring categories can become embedded in reimbursed, scalable, and operationally sustainable care pathways.

 

Key Market Drivers: What’s Fueling the U.S. Wireless Patient Monitoring Devices Market Boom?

The first major driver is the size and persistence of the U.S. chronic disease burden. Approximately 119.9 million adults have high blood pressure and about 92.9 million do not have it controlled below 130/80 mm Hg. Diabetes affects about 38 million U.S. adults, while chronic obstructive pulmonary disease affects roughly 4% of adults and rises sharply among older populations. These conditions require repeated measurement rather than one-time diagnosis. Connected blood pressure cuffs, continuous glucose monitors, pulse oximeters, smart scales, wearable ECG devices, and respiratory sensors convert monitoring from an occasional office activity into a longitudinal management process.

A second driver is population aging and multimorbidity. The 65-and-older population increased to 61.2 million in 2024 and is growing faster than the working-age population. Older patients are more likely to have concurrent cardiovascular, metabolic, respiratory, and mobility-related conditions, creating demand for multiparameter monitoring and simplified devices that require minimal setup. Aging also increases the importance of caregiver access, fall-risk awareness, medication-related surveillance, and post-discharge observation. Device suppliers that design for visual, cognitive, dexterity, and connectivity limitations will address a larger real-world patient pool than suppliers optimized only for digitally confident users.

A third driver is the economics of hospital capacity and clinical labor. U.S. hospitals manage more than 35 million admissions annually while facing persistent nursing and technical staffing pressure. Wireless monitoring can reduce repeated manual spot checks, maintain visibility during transport, extend surveillance to lower-acuity units, and support centralized monitoring models. The economic case is strongest when devices reduce low-value bedside tasks without transferring excessive alarm burden to remote teams. Procurement committees are increasingly comparing monitoring platforms on cost per monitored patient-day, staff minutes saved, alarm response, unplanned ICU transfer, and avoided deterioration rather than unit price alone.

A fourth driver is the expansion of hospital-at-home, post-acute, and early-discharge models. Health systems need a reliable way to monitor patients who would previously have remained in a staffed bed. Wireless multiparameter patches, cellular-enabled tablets and hubs, connected oximeters, thermometers, blood pressure devices, scales, and condition-specific sensors make higher-acuity home care operationally possible. These programs can release inpatient capacity and improve patient experience, but the devices must work across inconsistent home broadband environments. This makes preconfigured cellular connectivity and hybrid gateways especially valuable for high-risk populations.

A fifth driver is reimbursement and value-based care alignment. Medicare has covered remote patient monitoring since 2018, and utilization has increased significantly each year. The reimbursement structure recognizes device setup, device supply, and clinical treatment management as separate components, supporting recurring revenue opportunities for providers. Accountable care organizations, Medicare Advantage plans, and risk-bearing medical groups also use wireless monitoring to detect deterioration earlier and reduce avoidable utilization. The commercial opportunity is strongest where devices are paired with protocols that directly influence medication titration, escalation, or care-plan adjustment.

A sixth driver is the maturation of wireless technology. Bluetooth Low Energy supports low-power wearables and home devices, Wi-Fi enables high-bandwidth hospital monitoring, cellular connectivity removes dependence on patient-owned internet, and proprietary medical telemetry provides controlled performance in acute care. Battery efficiency, miniaturized sensors, adhesive materials, edge processing, cloud infrastructure, and smartphone interoperability have all improved. These advances are allowing longer wear times, lower device complexity, and more frequent data transmission while reducing the need for manual pairing or patient-entered readings.

A seventh driver is the clinical normalization of continuous data. Continuous glucose monitoring has demonstrated that patients and clinicians can change behavior when trends are visible rather than represented by isolated readings. Ambulatory ECG patches have similarly expanded arrhythmia detection beyond short-duration Holter monitoring. Hospitals are applying the same logic to respiratory rate, oxygen saturation, temperature, blood pressure, activity, and hemodynamic patterns. As clinicians become more comfortable with trend-based interpretation, monitoring products that provide validated trajectories and deterioration scores will gain advantage over devices that only reproduce conventional spot measurements on a screen.

An eighth driver is regulatory and cybersecurity discipline. Wireless devices create clinical value only when buyers trust their data integrity and network behavior. FDA attention to cybersecurity, software lifecycle management, interoperability, and postmarket vulnerability management is raising the technical threshold for market participation. The 2025 safety communication involving certain network-capable patient monitors demonstrated that unauthorized wireless functionality and data-routing vulnerabilities can become patient-safety and procurement issues. This will increase demand for secure-by-design products, transparent software bills of materials, patch governance, encrypted transmission, and enterprise network validation.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in wireless patient monitoring is moving away from device connectivity as a standalone feature. Connectivity is becoming expected; differentiation is shifting toward signal quality, wearability, predictive interpretation, workflow integration, and measurable operational impact. The most competitive systems are designed around an end-to-end clinical question: which patient is deteriorating, what action should be taken, who should receive the alert, and how should the intervention be documented?

Wearable multiparameter biosensors are one of the most important innovation areas. New patches and patient-worn devices can capture combinations of heart rate, respiratory rate, temperature, activity, posture, oxygen saturation, and single-lead ECG data over extended periods. Their value is highest in med-surg surveillance, post-operative recovery, oncology, infectious disease, and hospital-at-home use. Manufacturers are improving adhesive performance, skin tolerance, signal stability during movement, battery duration, and automated device onboarding. Longer wear time reduces replacement workload, but only if data quality remains clinically dependable.

Wireless cardiac monitoring is also evolving. Mobile cardiac telemetry, extended-wear ECG patches, smartphone-connected ECG, and enterprise telemetry are expanding the duration and location of rhythm surveillance. In hospitals, next-generation telemetry platforms are designed to maintain connectivity across units and during patient movement while improving alarm management. In ambulatory care, algorithms are becoming more precise in identifying atrial fibrillation, pauses, ventricular arrhythmias, and symptom-rhythm correlation. The commercial advantage increasingly comes from diagnostic yield and turnaround time rather than recording duration alone.

Continuous glucose monitoring is broadening the definition of patient monitoring. FDA clearance of over-the-counter CGM systems in 2024 expanded wireless glucose sensing beyond intensively managed insulin users. Longer-duration sensors, interoperable data, automated trend interpretation, and integration with digital coaching are creating a larger metabolic monitoring ecosystem. The segment will remain one of the market’s largest revenue contributors because it combines high-frequency sensor replacement with a broad and growing user base. However, manufacturers must distinguish clinically managed disease monitoring from consumer curiosity to sustain payer and provider value.

Artificial intelligence and edge analytics are becoming embedded in devices and gateways. Edge processing can check signal quality, compress data, detect threshold events, and maintain essential functionality during temporary connectivity loss. Cloud analytics can stratify patient risk across thousands of individuals and direct clinician attention to exceptions. The key innovation challenge is controlling false positives. Health systems will reject algorithms that generate more work than they eliminate. Vendors therefore need transparent validation, configurable thresholds, population-specific performance data, and evidence that alerting improves clinical action rather than simply increasing notifications.

Interoperability is another decisive innovation domain. Monitoring platforms are being designed to connect with electronic health records, nurse call systems, clinical communication tools, command centers, virtual care teams, and population health platforms. Open interfaces can improve adoption, but hospitals still require strong governance over data mapping, patient identity, cybersecurity, and change control. Enterprise vendors are responding with device orchestration, remote software updates, fleet analytics, and standardized user interfaces across bedside, transport, and home monitoring environments.

Manufacturers are also innovating through commercial models. Subscription pricing, monitoring-as-a-service, per-patient-per-month contracts, risk-sharing agreements, and managed device logistics are replacing some traditional one-time capital purchases. These models help providers scale without carrying excess inventory and shift responsibility for connectivity, replacement, and technical support to the vendor. The strongest contracts will link commercial terms to active patients, usable data days, device return rates, or documented outcomes instead of simple device shipment volume.

 

Segmentation Insights

The U.S. Wireless Patient Monitoring Devices Market is segmented on the basis of product type, application, end user, connectivity technology, and region. The segmentation reflects how clinical buyers evaluate the market: by the physiologic parameter monitored, the disease or care pathway supported, the site of care, the wireless architecture, and the regional concentration of demand.

 

By Product Type

Wireless Cardiac Monitoring Devices

Wireless cardiac monitoring devices represented an estimated 24.5% of market revenue in 2025, or approximately USD 2.85 billion. The segment includes mobile cardiac telemetry, extended Holter and patch-based ECG systems, implantable rhythm monitoring connectivity, bedside telemetry, transport monitors, and smartphone-connected ECG devices. Demand is supported by atrial fibrillation detection, syncope evaluation, post-ablation surveillance, medication management, and the need to maintain rhythm visibility outside traditional telemetry units. Growth will favor systems that combine high diagnostic yield, rapid report turnaround, long wear duration, and direct integration with cardiology workflow.

Connected Blood Glucose Monitoring Devices

Connected glucose monitoring accounted for roughly 22.0% of the 2025 market, equivalent to about USD 2.56 billion. Continuous glucose monitors dominate value because sensors are replaced frequently and data are transmitted wirelessly to readers, smartphones, caregivers, and clinical platforms. Growth is being expanded by wider insurance coverage, improved sensor accuracy, over-the-counter access, longer wear duration, and interest in metabolic risk management. The segment is highly competitive and innovation-intensive, with differentiation based on accuracy, sensor life, insertion experience, interoperability, alerting, and the ability to support both treatment decisions and longitudinal coaching.

Wireless Blood Pressure and Hemodynamic Monitoring Devices

Wireless blood pressure monitoring generated an estimated USD 1.46 billion in 2025, representing about 12.5% of the market. The category includes connected upper-arm cuffs, ambulatory blood pressure monitors, cellular hypertension kits, smart scales used in heart failure programs, and selected noninvasive hemodynamic devices. The addressable population is exceptionally large because nearly half of U.S. adults have hypertension. Market growth depends less on cuff availability and more on adherence, proper measurement technique, medication titration protocols, and whether clinicians can act efficiently on incoming readings.

Wireless Respiratory and Pulse Oximetry Devices

Wireless respiratory monitoring represented approximately 11.5% of 2025 revenue, or around USD 1.34 billion. Products include connected pulse oximeters, respiratory rate sensors, capnography-enabled monitoring, spirometry devices, sleep and ventilation monitoring accessories, and home respiratory surveillance systems. Adoption is driven by COPD, sleep-disordered breathing, post-operative respiratory risk, neonatal care, infectious respiratory disease, and home oxygen management. Continuous or trend-based respiratory monitoring is gaining attention because respiratory rate can deteriorate before conventional spot-check vital signs become abnormal.

Wearable Multiparameter and Biosensor Devices

Wearable multiparameter systems accounted for an estimated 19.0% of the market in 2025, equal to approximately USD 2.21 billion, and are expected to be the fastest-growing product group through 2035. These devices monitor two or more parameters through patches, armbands, wrist devices, chest sensors, or body-worn modules. The strongest opportunities are in med-surg surveillance, hospital-at-home, post-surgical recovery, oncology, and decentralized clinical trials. Procurement will be influenced by false-alarm performance, battery life, data continuity, adhesive tolerance, gateway requirements, and the ability to scale device logistics across large patient populations.

Wireless Maternal, Fetal, Neurological, Temperature, and Other Specialty Devices

Specialty wireless monitoring categories collectively represented about 10.5% of the 2025 market, or roughly USD 1.22 billion. The segment includes wireless fetal and maternal monitors, temperature sensors, seizure and neurological monitoring devices, fall and movement sensors, connected medication-adherence devices, and specialty post-procedure monitoring systems. These are smaller individual markets but can deliver high growth where wireless design removes a specific workflow constraint, such as allowing maternal mobility during labor, enabling continuous temperature trending, or supporting home neurological observation.

 

By Application

Cardiovascular Disease and Hypertension Management

Cardiovascular and hypertension applications formed the largest application segment, with an estimated 31% share in 2025. Wireless ECG, blood pressure, weight, oxygen saturation, and implant-linked monitoring are used to manage arrhythmias, heart failure, hypertension, ischemic disease, and post-procedure recovery. The economic rationale is strong because early intervention can prevent emergency utilization and because cardiology practices have established monitoring workflows. Growth will be concentrated in atrial fibrillation detection, remote medication titration, heart failure surveillance, and post-discharge monitoring after cardiac procedures.

Diabetes and Metabolic Disease Management

Diabetes and metabolic applications accounted for approximately 24% of 2025 market revenue. Continuous glucose monitoring is the primary contributor, but the application increasingly includes connected weight scales, blood pressure monitoring, activity data, and digital coaching inputs. The segment benefits from high patient frequency of use and strong consumer awareness. Through 2035, the most attractive opportunities will involve interoperable sensors, simplified access, integration with medication and nutrition management, and clinically credible use in non-insulin-treated populations.

Respiratory Disease and Sleep-Related Monitoring

Respiratory applications represented an estimated 14% share in 2025. Wireless pulse oximetry, respiratory rate monitoring, connected spirometry, sleep monitoring, and ventilation-related data are used in COPD, asthma, sleep apnea, post-operative monitoring, and home oxygen programs. The Midwest and South have particularly strong need because chronic respiratory disease prevalence is higher in many nonmetropolitan populations. Vendors that can maintain signal reliability during movement and avoid excessive low-specificity oxygen alerts will be better positioned for clinical adoption.

Post-Acute Care, Surgical Recovery, and Hospital-at-Home

Post-acute and decentralized acute care accounted for roughly 17% of 2025 market revenue and is projected to outgrow the market average. Wireless multiparameter devices allow health systems to discharge selected patients earlier while maintaining observation of vital signs and symptoms. The segment includes post-surgical recovery, heart failure transitions, pneumonia monitoring, oncology observation, and higher-acuity home care. Success depends on device simplicity, rapid deployment, 24-hour support, patient adherence, and clear escalation ownership between virtual teams and local clinicians.

Neurological, Maternal, Oncology, Infectious Disease, and Other Applications

Other clinical applications collectively accounted for about 14% of the 2025 market. Wireless monitoring supports seizure detection, maternal mobility, fetal surveillance, oncology toxicity monitoring, fever tracking, rehabilitation, fall-risk observation, and decentralized research. These markets are more fragmented, but they offer premium opportunities when devices are designed around a defined clinical protocol. Oncology monitoring is particularly promising because symptom and vital-sign changes between treatment visits can indicate adverse events before the next scheduled appointment.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems represented approximately 34% of market revenue in 2025. They purchase bedside monitors, patient-worn telemetry, central stations, transport monitoring, wearable surveillance systems, gateways, and enterprise software. Large systems typically evaluate wireless monitoring through cross-functional committees involving clinicians, nursing, information technology, biomedical engineering, cybersecurity, finance, and supply chain. Vendor consolidation, enterprise standardization, and service-level reliability are major determinants of market share.

Home Care and Hospital-at-Home Programs

Home-based care was the largest end-use category, accounting for an estimated 38% of 2025 revenue. This includes chronic disease monitoring, post-discharge programs, home health, virtual wards, and hospital-at-home pathways. The segment is driven by recurring sensor use and the scale of eligible patients. Cellular-enabled products have an advantage where broadband reliability or digital literacy is uncertain. Device vendors must also support shipping, onboarding, replacement, retrieval, cleaning, and reassignment because logistics performance directly affects program economics.

Physician Practices and Specialty Clinics

Physician practices and specialty clinics generated about 12% of 2025 market value. Cardiology, endocrinology, pulmonology, primary care, obstetrics, and neurology practices use wireless devices to extend monitoring between visits. These buyers prioritize reimbursement support, low administrative burden, simple reporting, and manageable alert volumes. Practice-level adoption can scale rapidly, but smaller organizations are more sensitive to changes in Medicare billing requirements and often depend on vendor-supported workflows.

Ambulatory, Post-Acute, and Long-Term Care Facilities

Ambulatory surgery centers, skilled nursing facilities, rehabilitation centers, dialysis providers, emergency medical services, and long-term care settings represented an estimated 10% share in 2025. These environments need portable, durable, and cost-efficient monitoring that can operate with fewer technical resources than major hospitals. Wireless products can improve transfer-of-care continuity and reduce avoidable hospital returns. The opportunity is strongest for monitoring protocols tied to high-risk transitions, respiratory instability, dialysis-related events, or post-procedure complications.

Payers, Digital Care Companies, and Research Organizations

Payers, digital care providers, contract research organizations, and decentralized trial sponsors accounted for approximately 6% of 2025 revenue. These users often deploy devices at population scale and require standardized data, rapid patient onboarding, and measurable engagement. Their purchasing model is frequently based on active members or monitored participants rather than equipment ownership. Growth will depend on evidence that device-enabled programs improve risk adjustment, close care gaps, reduce claims cost, or generate reliable real-world and clinical trial data.

 

By Connectivity Technology

Cellular-Connected Monitoring

Cellular connectivity accounted for an estimated 30% of the market in 2025 and is particularly important in home-based monitoring. Embedded LTE and emerging 5G-capable gateways reduce dependence on patient Wi-Fi and can simplify setup. Cellular products are attractive for high-risk, elderly, rural, and lower-income populations where broadband access may be inconsistent. Their disadvantages include recurring connectivity cost, carrier management, and potential coverage gaps. Multi-carrier capability and remote provisioning can materially improve performance.

Wi-Fi-Enabled Monitoring

Wi-Fi represented approximately 25% of 2025 market revenue and remains central to hospital patient monitoring. It supports continuous data transmission across enterprise networks and can integrate with mobile clinical applications. However, medical monitoring places more demanding requirements on roaming, latency, coverage, interference management, and network segmentation than ordinary enterprise devices. Hospitals increasingly require pre-deployment wireless surveys, validated network configurations, and coordinated responsibility between the monitoring vendor and internal information technology teams.

Bluetooth and Bluetooth Low Energy

Bluetooth and Bluetooth Low Energy accounted for roughly 24% of the market in 2025. The technology is widely used in cuffs, scales, pulse oximeters, CGMs, ECG devices, and wearable sensors because it supports low-power communication to smartphones or hubs. Its commercial strength is broad device compatibility and low component cost. Its operational weakness is pairing complexity and dependence on a nearby relay device. Vendors are reducing friction through pre-paired kits, background synchronization, and automated troubleshooting.

Proprietary Radiofrequency and Medical Telemetry Networks

Proprietary radiofrequency and dedicated telemetry solutions represented approximately 13% of 2025 revenue. These systems are used when acute care buyers prioritize predictable performance, controlled spectrum behavior, and enterprise-scale patient mobility. They can reduce dependence on general-purpose Wi-Fi but require dedicated infrastructure and vendor-specific expertise. This category will remain important in high-acuity environments, although procurement committees will closely examine total infrastructure cost and long-term upgrade flexibility.

Hybrid Multi-Network and IoT Gateway Architectures

Hybrid architectures represented an estimated 8% of the 2025 market but are expected to record the fastest connectivity growth through 2035. These systems can use Bluetooth from sensor to hub, Wi-Fi inside the hospital, and cellular outside the facility, with edge logic maintaining continuity when one network is unavailable. Hybrid designs are well suited to care pathways that cross settings. Their strategic value is resilience, but they increase device-management and cybersecurity complexity, making centralized orchestration essential.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Wireless Patient Monitoring Devices Market is geographically segmented into the South, Northeast, West, and Midwest. Regional performance is influenced by population growth, age distribution, chronic disease prevalence, health system concentration, hospital-at-home investment, rural connectivity, payer mix, academic medical center density, and the presence of digital health and medtech ecosystems. The South was the largest regional market in 2025 with an estimated 39% share, while the West is projected to record the fastest growth through 2035. The Northeast remains a high-value early-adoption region, and the Midwest provides a stable base for hospital monitoring, chronic disease surveillance, and rural connected-care deployment.

South

The South accounted for an estimated USD 4.54 billion in 2025, representing about 39% of the U.S. market. The region includes Texas, Florida, Georgia, North Carolina, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia, and the District of Columbia. Its leadership is supported by population scale, rapid growth in several metropolitan areas, high prevalence of hypertension, diabetes, obesity, and cardiovascular disease, and a large base of Medicare and Medicare Advantage beneficiaries. The South is expected to reach approximately USD 16.25 billion by 2035, supported by a CAGR near the national average.

Texas is the largest wireless patient monitoring market in the region and one of the largest nationally, with an estimated 2025 value above USD 1.0 billion. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major integrated delivery networks, academic centers, specialty hospitals, and fast-growing suburban populations. Texas offers strong demand for hospital telemetry, cardiac monitoring, diabetes devices, post-discharge programs, and employer-sponsored virtual care. Rural and border areas create a parallel need for cellular-first devices that can operate without reliable home broadband.

Florida is the second-largest Southern state market and benefits from one of the country’s oldest population profiles. Demand is especially strong for continuous glucose monitoring, connected blood pressure devices, arrhythmia monitoring, pulse oximetry, heart failure scales, and post-acute surveillance. The state’s large Medicare population makes reimbursement design and patient onboarding critical. Health systems in Miami, Tampa, Orlando, Jacksonville, and South Florida are also expanding virtual nursing, command-center, and home-based care capabilities, creating opportunities for enterprise monitoring platforms rather than single-device programs.

North Carolina, Georgia, Tennessee, Virginia, and Maryland are important growth markets because of expanding health systems, academic medical centers, and technology-oriented provider organizations. North Carolina combines major research institutions with rapidly growing urban markets in the Research Triangle and Charlotte. Georgia’s Atlanta-centered provider base supports enterprise monitoring and ambulatory cardiology. Tennessee has strong hospital and care-management companies, while Virginia and Maryland benefit from dense health system networks, federal healthcare activity, and sophisticated payer-provider collaboration.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, South Carolina, and West Virginia have high chronic disease burden and substantial rural or underserved populations. These states are clinically suitable for wireless monitoring, but adoption can be constrained by broadband gaps, digital literacy, provider staffing, and fragmented care delivery. The most effective commercial models will use preconfigured cellular devices, multilingual onboarding, centralized clinical support, and partnerships with regional health systems or Medicare Advantage plans. COPD and heart failure monitoring are particularly relevant in nonmetropolitan communities where emergency access and specialist availability are limited.

The South’s market opportunity is therefore split between premium enterprise adoption in large urban systems and scalable, low-friction monitoring in underserved communities. Vendors that can support both environments with one interoperable platform will have an advantage. State-level policy variation, Medicaid managed care structures, rural health funding, and health system consolidation will influence the pace of adoption. Texas, Florida, North Carolina, Georgia, Virginia, Tennessee, and Maryland are expected to remain the highest-value Southern markets through 2035.

West

The West represented an estimated USD 2.33 billion in 2025, or approximately 20% of the national market, and is expected to become the fastest-growing region. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. By 2035, the Western market is projected to reach approximately USD 10.20 billion, supported by an estimated CAGR of nearly 15.9%. Growth is driven by digital health adoption, technology investment, population expansion in the Mountain West, and strong interest in home-based and data-driven care.

California is the largest Western state market and an estimated USD 1.4-1.5 billion opportunity in 2025. The state combines a large and diverse patient population with academic medical centers, integrated delivery systems, technology companies, venture-backed digital health firms, and value-based care organizations. California providers are early adopters of wearable biosensors, continuous glucose monitoring, virtual care command centers, and AI-enabled patient prioritization. At the same time, the state’s scale creates complex requirements for interoperability, language access, Medicaid population management, and cybersecurity governance.

Washington and Oregon are important for enterprise connected-care adoption. Large integrated systems in these states have experience with telehealth, remote specialty care, and coordinated population health. Their markets favor interoperable monitoring, clinician-friendly dashboards, and home-based care pathways. Rural geography across eastern Washington and Oregon increases the relevance of cellular monitoring and remote respiratory or cardiac management. These states also have strong technology workforces that can support sophisticated analytics and device integration, although provider organizations still demand clear clinical validation.

Arizona, Nevada, Colorado, and Utah are high-growth markets. Arizona and Nevada are expanding rapidly and have rising older-adult populations, creating strong demand for cardiometabolic and post-acute monitoring. Colorado and Utah benefit from integrated provider networks, digitally engaged populations, and growing medical technology activity. Phoenix, Las Vegas, Denver, Salt Lake City, and surrounding suburban markets are likely to see above-average adoption of hospital-at-home monitoring, ambulatory cardiac devices, and connected chronic disease programs.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller revenue markets but strategically important for remote access. Geographic distance, specialist shortages, and dispersed populations strengthen the clinical case for wireless monitoring. However, harsh operating environments, limited broadband, shipping logistics, and device servicing can increase cost. Cellular and store-and-forward resilience, longer battery life, multilingual or culturally appropriate support, and compact kits are particularly important. Alaska and Hawaii also require supply-chain planning that differs from the continental market.

The West’s long-term advantage is the close interaction between technology development and clinical adoption. Companies often test new monitoring models with West Coast health systems before national expansion. The region is likely to lead in hybrid connectivity, AI-assisted triage, consumer-clinical device convergence, and risk-based contracting. California, Washington, Arizona, Colorado, Oregon, Utah, and Nevada will account for most Western revenue, while rural states will create high-value use cases for connectivity resilience and remote specialist support.

Northeast

The Northeast accounted for an estimated USD 2.68 billion in 2025, representing approximately 23% of the U.S. market. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, Vermont, New Hampshire, Rhode Island, and Delaware. It is projected to reach about USD 8.95 billion by 2035. Growth is somewhat slower than the West because the market is mature, but the Northeast remains one of the highest-value regions per patient due to advanced hospital infrastructure, dense specialist networks, academic medical centers, and rigorous adoption of clinically validated technology.

New York is the largest state market in the Northeast, with an estimated 2025 opportunity near USD 0.7 billion. New York City health systems require large-scale wireless telemetry, transport monitoring, and centralized surveillance, while upstate and rural communities benefit from remote chronic disease management. The state’s diversity creates demand for multilingual onboarding, Medicaid-compatible programs, and enterprise integration across complex delivery networks. Cardiac monitoring, diabetes management, and hospital-at-home are leading opportunities.

Massachusetts is strategically influential because of its concentration of teaching hospitals, medical device companies, digital health firms, and clinical research organizations. Although its population is smaller than New York or Pennsylvania, the state has high early-adoption value. Hospitals in the Boston area often evaluate wearable sensors, AI-enabled monitoring, and decentralized trial technologies before broader commercialization. Procurement expectations are demanding: vendors need strong evidence, cybersecurity documentation, interoperability, and measurable clinical or workforce benefit.

Pennsylvania and New Jersey form a large, clinically diverse corridor with major academic systems, community hospitals, suburban populations, and older-adult demand. Pennsylvania supports strong hospital monitoring and post-acute opportunities across Philadelphia, Pittsburgh, and regional networks. New Jersey benefits from dense payer, pharmaceutical, medtech, and provider activity. Both states are attractive for cardiology, diabetes, respiratory, and oncology monitoring programs, particularly where device data can be connected to specialty-care pathways and value-based contracts.

Connecticut, Rhode Island, Delaware, New Hampshire, Vermont, and Maine are smaller but relevant markets. Connecticut and Rhode Island have concentrated provider networks that can support enterprise standardization. Delaware has an older population and a manageable health system scale suitable for statewide or payer-led programs. Maine, Vermont, and New Hampshire have older and more rural populations, increasing the need for connected blood pressure, cardiac, respiratory, and post-discharge monitoring. Cellular coverage and device logistics are key commercial considerations in northern New England.

The Northeast will continue to influence national standards for evidence and clinical integration. Device manufacturers often use leading academic centers in the region for trials, protocol development, and specialist advocacy. Market success will depend on integration with established electronic health record environments, compliance with stringent cybersecurity review, and a credible plan for reducing clinician burden. New York, Pennsylvania, New Jersey, and Massachusetts will remain the largest state opportunities, while northern New England will provide targeted growth in aging and rural care models.

Midwest

The Midwest represented an estimated USD 2.10 billion in 2025, accounting for approximately 18% of national revenue. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. The market is expected to reach approximately USD 7.04 billion by 2035, supported by stable hospital demand, strong regional health systems, high chronic disease prevalence in several states, and increasing use of remote monitoring to connect rural communities with metropolitan referral centers.

Illinois is the largest Midwestern state market, supported by Chicago’s academic medical centers, large integrated systems, specialty practices, and diverse patient base. Enterprise telemetry, cardiac diagnostics, diabetes monitoring, and transitional care are major opportunities. Downstate Illinois has more rural and aging communities, creating demand for low-complexity home devices and centralized clinical monitoring. Vendors must be able to serve both high-acuity urban systems and geographically dispersed community networks.

Ohio and Michigan have substantial cardiovascular, diabetes, and respiratory disease burden and strong hospital infrastructure. Ohio’s major provider systems support large-scale patient monitoring, virtual care, and cardiac programs. Michigan combines academic centers, integrated networks, and a large manufacturing-oriented population with chronic disease needs. Wireless cardiac monitoring, hypertension management, respiratory surveillance, and post-discharge programs are likely to generate durable growth in both states.

Minnesota and Wisconsin are strategically important because of their medtech heritage, integrated care organizations, and strong clinical quality culture. Minnesota is influential in cardiac monitoring, chronic disease devices, and medical technology commercialization. Wisconsin has large regional systems capable of enterprise standardization and rural outreach. Both states are attractive for monitoring platforms that can demonstrate operational discipline, strong service, and integration rather than relying on high-touch manual program support.

Indiana, Missouri, Iowa, and Kansas provide steady demand across community hospitals, specialty clinics, and post-acute settings. Indianapolis, St. Louis, Kansas City, Des Moines, and other metropolitan areas have strong health system anchors, while surrounding rural areas create a need for remote access. Cellular blood pressure monitoring, heart failure scales, pulse oximetry, and ambulatory cardiac devices can support care pathways where specialist visits require long travel distances.

Nebraska, North Dakota, and South Dakota are smaller revenue markets but have a strong strategic need for wireless monitoring because of sparse population and regional referral patterns. Providers in these states value device reliability, battery life, low training burden, and rapid technical support. The Midwest overall is less likely than the West to generate consumer-led adoption, but it offers a dependable environment for clinically integrated programs. Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, and Missouri will account for most regional value through 2035.

 

Key Market Players

The U.S. Wireless Patient Monitoring Devices Competitive Landscape is moderately consolidated in hospital monitoring, continuous glucose monitoring, and large-scale cardiac diagnostics, while wearable biosensors, remote care platforms, and specialty monitoring remain more fragmented. Competition is increasingly platform-based. Leading companies are building connected ecosystems that combine sensors, patient devices, gateways, central monitoring, analytics, enterprise services, and clinical workflow integration. Smaller innovators can still win share when they solve a defined problem such as extended-wear monitoring, simplified home deployment, or high-quality multiparameter data from a low-burden wearable.

Some of the key players in the U.S. Wireless Patient Monitoring Devices industry are:

• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Baxter International Inc. (Hillrom)
• Medtronic plc
• Abbott Laboratories
• Danaher Corporation / Masimo
• Nihon Kohden Corporation
• Siemens Healthineers AG
• OMRON Healthcare, Inc.
• DexCom, Inc.
• Insulet Corporation
• iRhythm Technologies, Inc.
• Boston Scientific Corporation (Preventice Solutions)
• ZOLL Medical Corporation
• ResMed Inc.
• BioIntelliSense, Inc.
• VitalConnect, Inc.
• Sotera Wireless, Inc.
• AliveCor, Inc.
• Withings Health Solutions
• Current Health (Best Buy Health)
• Biotricity Inc.
• Honeywell International Inc.
• Nonin Medical, Inc.
• Spacelabs Healthcare

Philips, GE HealthCare, Baxter, Nihon Kohden, Spacelabs, Siemens Healthineers, and Danaher-owned Masimo have strong positions in acute-care monitoring because they combine bedside devices, central monitoring, sensors, network expertise, and hospital service organizations. Medtronic, Abbott, Dexcom, Insulet, iRhythm, Boston Scientific, ZOLL, and ResMed compete through disease-specific monitoring, implant connectivity, wearable diagnostics, or recurring sensor models. BioIntelliSense, VitalConnect, Sotera Wireless, AliveCor, Withings, Current Health, Biotricity, Honeywell, and Nonin bring specialized capabilities in wearable biosensing, home monitoring, mobile ECG, pulse oximetry, and distributed care.

Competitive share through 2035 will be influenced by FDA clearances, clinical evidence, algorithm performance, cybersecurity maturity, EHR integration, connectivity reliability, sensor economics, and the ability to support implementation across multiple sites of care. Large vendors can bundle monitoring with enterprise contracts and service agreements. Focused innovators can defend share by achieving superior wearability, diagnostic yield, or deployment simplicity. Partnerships with health systems, payers, care-management companies, and electronic health record vendors will become as important as traditional distributor relationships.

The June 2026 completion of Danaher’s acquisition of Masimo for approximately USD 9.9 billion highlights the strategic value of patient monitoring and sensor technology. Consolidation is likely to continue because monitoring creates recurring consumable revenue, clinical data assets, and entry into acute-care workflows. Buyers should expect larger platform companies to acquire niche sensor, analytics, or remote-care capabilities, while independent firms will focus on interoperable products that can connect to multiple enterprise environments.

 

Recent Developments

Recent developments in the U.S. Wireless Patient Monitoring Devices Market show simultaneous expansion and tightening of operating standards. Medicare remote patient monitoring utilization continued to grow in 2024, with payments exceeding USD 500 million. This confirms strong provider demand but also increases scrutiny of whether patients receive appropriate setup, device supply, and clinical treatment management. Compliance capability is becoming a product feature: vendors need audit-ready data on device assignment, transmission days, patient consent, clinician interaction, and escalation activity.

CMS updated its remote patient monitoring guidance in 2026 to emphasize the three required components of setup and education, connected-device supply, and treatment management. The current framework broadly supports acute and chronic conditions and allows multiple physiologic parameters, including blood pressure, weight, glucose, and oxygen saturation. The policy direction favors devices that automatically upload data and are integrated into a documented treatment process. Vendors that rely on patient-entered values or weak clinical engagement will face greater reimbursement and retention risk.

Cybersecurity became a more visible procurement issue after the FDA’s 2025 safety communication regarding vulnerabilities in certain Contec and Epsimed patient monitors. The subsequent patch removed networking functionality from affected devices, illustrating that wireless capability cannot be treated as an ungoverned add-on. Health systems are increasing review of device software, remote access, network destinations, patch mechanisms, data encryption, and postmarket support. FDA’s updated cybersecurity guidance in 2026 further reinforces secure product lifecycle expectations.

Continuous glucose monitoring expanded beyond traditional prescription pathways. The FDA cleared the first over-the-counter CGM for adults in March 2024 and expanded over-the-counter access in 2026 to younger users for a qualifying system. These actions broaden the wireless monitoring population and create new retail, employer, and preventive-care channels. They also increase the need to distinguish medical decision support from wellness use and to ensure that consumers understand when professional consultation is required.

Hospital telemetry and enterprise monitoring platforms are being redesigned around workforce efficiency and patient mobility. Newer platforms emphasize continuous connectivity beyond the bedside, centralized surveillance, roaming across care areas, and better alarm management. This responds to a practical problem: high alarm volumes and fragmented data can reduce the value of monitoring. Hospitals are therefore prioritizing configurable alarm strategies, analytics, and standardized monitoring workflows across units rather than simply adding more connected devices.

Market consolidation accelerated in 2026 when Danaher completed its acquisition of Masimo. The transaction combines a major diagnostics platform with a leading pulse oximetry, sensor, and patient monitoring portfolio. Strategically, the deal demonstrates that acute-care monitoring is viewed as a high-value diagnostics and data opportunity. Additional consolidation is likely around ambulatory cardiac monitoring, wearable biosensors, device logistics, and remote care orchestration as larger companies seek complete monitoring ecosystems.

The market is also seeing a shift from pilot programs to contract renewal discipline. Health systems and payers are evaluating active device utilization, patient adherence, clinical response rates, technical support tickets, device loss, readmission impact, and cost per successful monitoring episode. Programs that cannot demonstrate operational performance are being narrowed or redesigned. This creates a favorable environment for vendors that provide implementation analytics and transparent outcome reporting, even when their device price is higher than basic connected alternatives.

 

Conclusion

The U.S. Wireless Patient Monitoring Devices Market Size & Share is positioned for strong expansion from USD 11.65 billion in 2025 to USD 42.44 billion by 2035, supported by a 13.80% CAGR during 2026-2035. The market’s long-term strength is grounded in chronic disease prevalence, population aging, hospital capacity pressure, reimbursement for remote physiologic monitoring, and the migration of care into ambulatory and home settings. Wireless monitoring is becoming an infrastructure requirement rather than an optional digital feature.

The most attractive growth opportunities will come from wearable multiparameter biosensors, continuous glucose monitoring, ambulatory cardiac diagnostics, cellular home-monitoring kits, enterprise telemetry, respiratory surveillance, and hybrid connectivity architectures. Mature products such as connected blood pressure cuffs and pulse oximeters will remain important, but value growth will depend on adherence, clinical action, and integration. Devices that generate data without a manageable workflow will face pricing pressure and program attrition.

Regional opportunity will be led by the South because of population scale and chronic disease burden, followed by the Northeast’s high-value clinical base, the West’s innovation-driven growth, and the Midwest’s stable hospital and rural-care demand. Texas, Florida, California, New York, Pennsylvania, Illinois, North Carolina, Georgia, Massachusetts, Ohio, Washington, Arizona, Michigan, Virginia, and Tennessee will remain especially important state markets. Smaller rural states will generate targeted demand for cellular connectivity, low-complexity deployment, and remote specialist support.

For clients evaluating this market, the central strategic issue is not simply which sensor has the best specification. The decisive question is which vendor can convert reliable wireless data into clinically accepted action at sustainable cost. Manufacturers that combine validated devices, resilient connectivity, cybersecurity, interoperability, service logistics, reimbursement support, and outcome evidence will define the next decade of the U.S. wireless patient monitoring devices industry.

 

TABLE OF CONTENT

1. U.S. Wireless Patient Monitoring Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Wireless Patient Monitoring Device Manufacturers
1.6.2. Sensor, Semiconductor, Connectivity Module, and Component Suppliers
1.6.3. Software, Cloud Platform, and Clinical Analytics Providers
1.6.4. Hospitals, Health Systems, and Integrated Delivery Networks
1.6.5. Physician Practices, Specialty Clinics, and Ambulatory Care Providers
1.6.6. Home Healthcare, Remote Patient Monitoring, and Hospital-at-Home Providers
1.6.7. Group Purchasing Organizations, Distributors, and Channel Partners
1.6.8. Payers, Regulators, Employers, and Clinical Decision-Makers
What this section provides: This section defines the market boundary, device inclusion criteria, study scope, research methodology, assumptions, and stakeholder ecosystem used to measure and validate the U.S. wireless patient monitoring devices market.

2. U.S. Wireless Patient Monitoring Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Priority Clinical and Commercial Adoption Themes
What this section provides: This section gives decision-makers a concise view of market size, growth direction, device adoption, care-setting migration, competitive intensity, reimbursement relevance, and priority opportunity areas.

3. U.S. Wireless Patient Monitoring Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Burden of Chronic and Cardiometabolic Diseases
3.1.2. Expansion of Remote Patient Monitoring and Virtual Care Programs
3.1.3. Growth of Hospital-at-Home and Post-Discharge Monitoring Models
3.1.4. Increasing Demand for Continuous and Real-Time Physiological Data
3.1.5. Shortage of Clinical Staff and Need for Workflow Automation
3.1.6. Growth in Connected Cardiac, Respiratory, and Glucose Monitoring
3.1.7. Increasing Medicare and Commercial Payer Support for Remote Monitoring
3.2. Restraints and Their Impact Analysis
3.2.1. High Initial Device, Platform, and Integration Costs
3.2.2. Cybersecurity, Data Privacy, and Patient Consent Concerns
3.2.3. Device Connectivity Failures and Data Reliability Risk
3.2.4. Reimbursement Complexity and Documentation Requirements
3.2.5. Alert Fatigue and Clinical Workflow Burden
3.2.6. Digital Access and Patient Adherence Limitations
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Assisted Early Deterioration Detection
3.3.2. Multi-Parameter Wearable Monitoring Platforms
3.3.3. Cellular-Enabled Devices for Underserved and Rural Populations
3.3.4. Enterprise Remote Monitoring Command Centers
3.3.5. Wireless Monitoring for Decentralized Clinical Trials
3.3.6. Device-as-a-Service and Outcome-Based Commercial Models
3.3.7. Integration with Electronic Health Records and Clinical Decision Support
3.4. Challenges and Their Impact Analysis
3.4.1. Interoperability Across Devices, Platforms, and Health IT Systems
3.4.2. Clinical Validation of Consumer-Grade and Hybrid Monitoring Technologies
3.4.3. Scaling Patient Enrollment Without Increasing Clinical Labor
3.4.4. Maintaining Long-Term Patient Engagement and Device Compliance
3.4.5. Managing Supply Chain, Battery Life, and Device Replacement Cycles
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital and Health System Capital Procurement Behavior Analysis
3.8. Remote Monitoring Program Return-on-Investment Analysis
What this section provides: This section explains the clinical, commercial, reimbursement, technological, and operational forces shaping market demand, helping clients evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Wireless Patient Monitoring Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, Cloud Connectivity, and AI-Based Clinical Triage
4.6. Application & Innovation Landscape
4.7. FDA Medical Device and Cybersecurity Framework Analysis
4.8. CMS Remote Physiological Monitoring and Remote Therapeutic Monitoring Reimbursement Landscape
4.9. HIPAA, Data Privacy, Interoperability, and Wireless Connectivity Requirements
4.10. FCC Spectrum, Cellular Network, and Connected Device Considerations
4.11. Government Initiatives, Public Health Programs, and Virtual Care Expansion
4.12. Import Restrictions, Semiconductor Availability, and Tariff Impact
4.13. Impact of Escalating Geopolitical Tensions
4.14. Hospital Value Analysis Committee Decision Framework
4.15. Enterprise Technology Integration and Vendor Risk Assessment
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, cybersecurity, pricing, connectivity, supply chain, interoperability, and health system procurement dynamics.

5. U.S. Wireless Patient Monitoring Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Wireless Cardiac Monitoring Devices
5.1.2.1. Wireless Electrocardiogram Monitors
5.1.2.2. Mobile Cardiac Telemetry Devices
5.1.2.3. Cardiac Event Monitors
5.1.2.4. Wearable ECG Patches
5.1.2.5. Wireless Holter Monitoring Devices
5.1.2.6. Connected Implantable Cardiac Monitoring Systems
5.1.3. Wireless Blood Pressure Monitoring Devices
5.1.3.1. Connected Upper-Arm Blood Pressure Monitors
5.1.3.2. Wireless Wrist Blood Pressure Monitors
5.1.3.3. Ambulatory Blood Pressure Monitoring Devices
5.1.3.4. Continuous and Cuffless Blood Pressure Monitoring Devices
5.1.4. Wireless Blood Glucose Monitoring Devices
5.1.4.1. Continuous Glucose Monitoring Devices
5.1.4.2. Flash Glucose Monitoring Devices
5.1.4.3. Connected Blood Glucose Meters
5.1.4.4. Integrated Glucose and Insulin Management Devices
5.1.5. Wireless Respiratory and Oxygen Monitoring Devices
5.1.5.1. Wireless Pulse Oximeters
5.1.5.2. Connected Spirometers
5.1.5.3. Wireless Capnography Devices
5.1.5.4. Respiratory Rate Monitoring Sensors
5.1.5.5. Connected Sleep and Ventilation Monitoring Devices
5.1.6. Wireless Multiparameter and Other Monitoring Devices
5.1.6.1. Multiparameter Wearable Monitors
5.1.6.2. Wireless Temperature Monitoring Devices
5.1.6.3. Wireless Weight and Fluid Status Monitoring Devices
5.1.6.4. Fetal and Maternal Monitoring Devices
5.1.6.5. Neurological and Movement Monitoring Devices
5.1.6.6. Medication Adherence and Connected Diagnostic Devices
What this section provides: This section identifies the wireless monitoring device categories expected to generate the largest revenue contribution, highest utilization, and strongest growth through 2035.

6. U.S. Wireless Patient Monitoring Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Cardiovascular Disease and Arrhythmia Monitoring
6.1.2.1. Atrial Fibrillation and Rhythm Surveillance
6.1.2.2. Hypertension Management
6.1.2.3. Heart Failure Monitoring
6.1.2.4. Post-Cardiac Procedure Monitoring
6.1.3. Diabetes and Metabolic Disease Management
6.1.3.1. Continuous Glucose Monitoring
6.1.3.2. Insulin Therapy Optimization
6.1.3.3. Gestational Diabetes Monitoring
6.1.3.4. Obesity and Cardiometabolic Risk Management
6.1.4. Respiratory and Sleep Disorder Monitoring
6.1.4.1. Chronic Obstructive Pulmonary Disease Monitoring
6.1.4.2. Asthma Monitoring
6.1.4.3. Sleep Apnea Monitoring
6.1.4.4. Post-Infectious and Pulmonary Rehabilitation Monitoring
6.1.5. Acute, Critical, and Post-Acute Care Monitoring
6.1.5.1. Inpatient Continuous Monitoring
6.1.5.2. Emergency and Step-Down Unit Monitoring
6.1.5.3. Post-Surgical Monitoring
6.1.5.4. Post-Discharge and Readmission Prevention
6.1.6. Home-Based and Preventive Health Monitoring
6.1.6.1. Hospital-at-Home Programs
6.1.6.2. Elderly and Frailty Monitoring
6.1.6.3. Maternal and Fetal Monitoring
6.1.6.4. Population Health and Preventive Monitoring
6.1.6.5. Decentralized Clinical Trial Monitoring
What this section provides: This section helps clients understand demand by clinical use case and identify applications with strong chronic disease burden, reimbursement relevance, readmission-reduction potential, and technology adoption.

7. U.S. Wireless Patient Monitoring Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Acute-Care Hospitals
7.1.2.2. Academic Medical Centers
7.1.2.3. Community Hospitals
7.1.2.4. Critical Access and Rural Hospitals
7.1.3. Physician Practices and Specialty Clinics
7.1.3.1. Cardiology Practices
7.1.3.2. Endocrinology and Diabetes Clinics
7.1.3.3. Pulmonology and Sleep Clinics
7.1.3.4. Primary Care and Internal Medicine Practices
7.1.4. Ambulatory, Emergency, and Post-Acute Care Providers
7.1.4.1. Ambulatory Surgery Centers
7.1.4.2. Urgent Care and Emergency Care Providers
7.1.4.3. Rehabilitation and Post-Acute Care Centers
7.1.5. Home Healthcare and Remote Patient Monitoring Providers
7.1.5.1. Home Health Agencies
7.1.5.2. Virtual Care and RPM Service Providers
7.1.5.3. Hospital-at-Home Operators
7.1.5.4. Durable Medical Equipment Providers
7.1.6. Long-Term Care and Senior Care Facilities
7.1.6.1. Skilled Nursing Facilities
7.1.6.2. Assisted Living Communities
7.1.6.3. Continuing Care Retirement Communities
7.1.6.4. Hospice and Palliative Care Providers
What this section provides: This section explains which care settings and customer groups are expected to drive device purchasing, patient enrollment, recurring monitoring utilization, and enterprise platform adoption.

8. U.S. Wireless Patient Monitoring Devices Market – By Connectivity Technology

8.1. Overview
8.1.1. Segment Share Analysis, By Connectivity Technology, 2025 & 2035 (%)
8.1.2. Bluetooth and Bluetooth Low Energy
8.1.2.1. Smartphone-Connected Devices
8.1.2.2. Hub-Connected Monitoring Devices
8.1.2.3. Wearable Sensor Networks
8.1.3. Wi-Fi-Enabled Monitoring
8.1.3.1. Hospital Wi-Fi Monitoring Networks
8.1.3.2. Home Wi-Fi Monitoring Devices
8.1.3.3. Cloud-Connected Multiparameter Systems
8.1.4. Cellular Connectivity
8.1.4.1. 4G LTE-Enabled Devices
8.1.4.2. 5G-Enabled Monitoring Devices
8.1.4.3. LTE-M and Narrowband IoT Devices
8.1.4.4. Cellular Hubs and Gateways
8.1.5. Short-Range and Proprietary Wireless Technologies
8.1.5.1. Zigbee
8.1.5.2. Near-Field Communication
8.1.5.3. Radio-Frequency and Proprietary Protocols
8.1.5.4. Medical Body Area Networks
8.1.6. Hybrid and Multi-Connectivity Platforms
8.1.6.1. Bluetooth-to-Cellular Systems
8.1.6.2. Wi-Fi-to-Cellular Failover Systems
8.1.6.3. Cloud-Integrated Device Ecosystems
8.1.6.4. Edge-Computing and Gateway-Based Monitoring
What this section provides: This section evaluates the connectivity technologies supporting wireless patient monitoring, including their reliability, clinical suitability, infrastructure requirements, scalability, and adoption outlook.

9. U.S. Wireless Patient Monitoring Devices Market – By Procurement and Deployment Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement and Deployment Model, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchases
9.1.2.2. Enterprise Device Standardization Contracts
9.1.2.3. Department-Level and Service-Line Procurement
9.1.3. Integrated Delivery Network and Group Purchasing Organization Contracts
9.1.3.1. IDN Enterprise Agreements
9.1.3.2. GPO-Negotiated Contracts
9.1.3.3. Multi-Year Volume-Based Agreements
9.1.4. Subscription and Device-as-a-Service Models
9.1.4.1. Per-Patient-Per-Month Models
9.1.4.2. Device Leasing and Rental Models
9.1.4.3. Software and Analytics Subscription Models
9.1.4.4. Outcome-Based and Shared-Savings Models
9.1.5. Distributor, Specialty Supplier, and DME Channel Sales
9.1.5.1. Medical Device Distributors
9.1.5.2. Durable Medical Equipment Providers
9.1.5.3. Pharmacy and Specialty Retail Channels
9.1.6. Virtual Care and Outsourced Remote Monitoring Partnerships
9.1.6.1. Full-Service RPM Programs
9.1.6.2. Third-Party Clinical Monitoring Centers
9.1.6.3. White-Label Monitoring Platforms
9.1.6.4. Employer and Payer-Sponsored Programs
What this section provides: This section helps clients understand how wireless monitoring devices and platforms are purchased, deployed, financed, contracted, and operationalized across U.S. healthcare settings.

10. U.S. Wireless Patient Monitoring Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Chronic Disease Burden and Patient Monitoring Demand Analysis
10.1.4. Regional Hospital, Home Health, and Virtual Care Infrastructure Analysis
10.1.5. Regional Reimbursement and Remote Monitoring Adoption Dynamics
10.1.6. Regional Connectivity, Broadband, and Digital Access Analysis

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Wireless Patient Monitoring Device Manufacturers and Connected Care Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Wireless Patient Monitoring Device Manufacturers and Connected Care Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Wireless Patient Monitoring Device Manufacturers and Connected Care Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Wireless Patient Monitoring Device Manufacturers and Connected Care Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement and Deployment Model, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, chronic disease demand centers, connected care adoption hotspots, hospital-at-home opportunities, and state-level commercial potential.

11. U.S. Wireless Patient Monitoring Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Product Portfolio Breadth
11.3.2. Clinical Evidence and Regulatory Positioning
11.3.3. Connectivity and Interoperability Capabilities
11.3.4. Hospital and Home Monitoring Presence
11.3.5. Pricing and Commercial Model Comparison
11.3.6. U.S. Distribution and Strategic Partnership Strength
11.4. Company Profiles
11.4.1. Philips
11.4.2. GE HealthCare
11.4.3. Medtronic
11.4.4. Abbott Laboratories
11.4.5. Masimo Corporation
11.4.6. Baxter International
11.4.7. Nihon Kohden Corporation
11.4.8. Boston Scientific Corporation
11.4.9. Dexcom
11.4.10. Insulet Corporation
11.4.11. iRhythm Technologies
11.4.12. ZOLL Medical Corporation
11.4.13. ResMed
11.4.14. OMRON Healthcare
11.4.15. AliveCor
11.4.16. BioIntelliSense
11.4.17. VivaLNK
11.4.18. Current Health
11.4.19. Health Recovery Solutions
11.4.20. Spacelabs Healthcare
11.4.21. Nonin Medical
11.4.22. BIOTRONIK
11.4.23. Sibel Health
11.4.24. Empatica
11.4.25. Withings Health Solutions
Note: Each company profile will include company overview, wireless monitoring portfolio, U.S. market strategy, financial positioning, clinical validation, regulatory updates, connectivity capabilities, partnerships, reimbursement alignment, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, device and platform positioning, innovation direction, commercial-model comparison, and strategic intelligence on leading wireless patient monitoring companies.

12. U.S. Wireless Patient Monitoring Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Predictive Monitoring
12.2.2. Continuous Cuffless and Non-Invasive Monitoring
12.2.3. Multi-Parameter Wearable Biosensors
12.2.4. 5G, LTE-M, and Cellular-First Monitoring Devices
12.2.5. Edge Computing and Automated Clinical Triage
12.2.6. Digital Biomarkers and Personalized Risk Scoring
12.2.7. Contactless and Ambient Patient Monitoring
12.3. Emerging Business Trends
12.3.1. Enterprise Remote Monitoring Command Centers
12.3.2. Device-as-a-Service Models
12.3.3. Clinical Monitoring Outsourcing
12.3.4. Payer-Provider Connected Care Partnerships
12.3.5. Decentralized Clinical Trial Expansion
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Future Reimbursement and Regulatory Scenarios
What this section provides: This section prepares clients for technology shifts, reimbursement evolution, changing care models, investment opportunities, and potential market adoption scenarios through 2035.

13. U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations

13.1. Recommendations for Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Physician Practices and Specialty Clinics
13.4. Recommendations for Home Healthcare and Remote Monitoring Providers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors, GPOs, and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Reimbursement and Evidence-Generation Strategy
13.11. Cybersecurity, Interoperability, and Data Governance Priorities
13.12. State and Regional Market Entry Prioritization
What this section provides: This section converts market intelligence into actionable recommendations for product development, commercialization, clinical evidence, reimbursement planning, channel expansion, investment decisions, and competitive differentiation.

14. U.S. Wireless Patient Monitoring Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Medical and Clinical Decision Disclaimer
14.7. Regulatory and Reimbursement Change Disclaimer
What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, forecasting assumptions, and potential changes in clinical, regulatory, and reimbursement conditions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Wireless Patient Monitoring Devices Market: Market Definition and Scope
TABLE 3: U.S. Wireless Patient Monitoring Devices Market: Research Methodology Framework
TABLE 4: U.S. Wireless Patient Monitoring Devices Market: Key Assumptions
TABLE 5: U.S. Wireless Patient Monitoring Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Wireless Patient Monitoring Devices Market: Stakeholder Analysis
TABLE 7: U.S. Wireless Patient Monitoring Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Wireless Patient Monitoring Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Wireless Patient Monitoring Devices Market: Market Attractiveness Index
TABLE 10: U.S. Wireless Patient Monitoring Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Wireless Patient Monitoring Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Wireless Patient Monitoring Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Wireless Patient Monitoring Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Wireless Patient Monitoring Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Wireless Patient Monitoring Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Wireless Patient Monitoring Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Wireless Patient Monitoring Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Wireless Patient Monitoring Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Wireless Patient Monitoring Devices Market: Hospital and Health System Capital Procurement Behavior Matrix
TABLE 20: U.S. Wireless Patient Monitoring Devices Market: Remote Monitoring Program Return-on-Investment Analysis
TABLE 21: U.S. Wireless Patient Monitoring Devices Market: PESTEL Analysis
TABLE 22: U.S. Wireless Patient Monitoring Devices Market: Porter’s Five Forces Analysis
TABLE 23: U.S. Wireless Patient Monitoring Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 24: U.S. Wireless Patient Monitoring Devices Market: Value Chain Analysis
TABLE 25: U.S. Wireless Patient Monitoring Devices Market: Supply Chain Analysis
TABLE 26: U.S. Wireless Patient Monitoring Devices Market: Digitalization, Cloud Connectivity and AI-Based Clinical Triage Impact
TABLE 27: U.S. Wireless Patient Monitoring Devices Market: Application & Innovation Landscape
TABLE 28: U.S. Wireless Patient Monitoring Devices Market: FDA Medical Device and Cybersecurity Framework Analysis
TABLE 29: U.S. Wireless Patient Monitoring Devices Market: CMS RPM and RTM Reimbursement Landscape
TABLE 30: U.S. Wireless Patient Monitoring Devices Market: HIPAA, Data Privacy and Interoperability Requirements
TABLE 31: U.S. Wireless Patient Monitoring Devices Market: FCC Spectrum and Wireless Connectivity Considerations
TABLE 32: U.S. Wireless Patient Monitoring Devices Market: Government Initiatives and Virtual Care Programs
TABLE 33: U.S. Wireless Patient Monitoring Devices Market: Import Restrictions, Semiconductor Availability and Tariff Impact
TABLE 34: U.S. Wireless Patient Monitoring Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 35: U.S. Wireless Patient Monitoring Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 36: U.S. Wireless Patient Monitoring Devices Market: Enterprise Technology Integration and Vendor Risk Assessment
TABLE 37: U.S. Wireless Patient Monitoring Devices Market: Product Type Snapshot, 2025
TABLE 38: Segment Dashboard; Definition and Scope, by Product Type
TABLE 39: U.S. Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 40: U.S. Wireless Patient Monitoring Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 41: U.S. Wireless Patient Monitoring Devices Market: Wireless Cardiac Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Wireless Patient Monitoring Devices Market: Wireless Blood Pressure Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Wireless Patient Monitoring Devices Market: Wireless Blood Glucose Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Wireless Patient Monitoring Devices Market: Wireless Respiratory and Oxygen Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Wireless Patient Monitoring Devices Market: Wireless Multiparameter and Other Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Wireless Patient Monitoring Devices Market: Application Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Application
TABLE 48: U.S. Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 49: U.S. Wireless Patient Monitoring Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 50: U.S. Wireless Patient Monitoring Devices Market: Cardiovascular Disease and Arrhythmia Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Wireless Patient Monitoring Devices Market: Diabetes and Metabolic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Wireless Patient Monitoring Devices Market: Respiratory and Sleep Disorder Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Wireless Patient Monitoring Devices Market: Acute, Critical and Post-Acute Care Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Wireless Patient Monitoring Devices Market: Home-Based and Preventive Health Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Wireless Patient Monitoring Devices Market: End User Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by End User
TABLE 57: U.S. Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 58: U.S. Wireless Patient Monitoring Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 59: U.S. Wireless Patient Monitoring Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Wireless Patient Monitoring Devices Market: Physician Practices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Wireless Patient Monitoring Devices Market: Ambulatory, Emergency and Post-Acute Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Wireless Patient Monitoring Devices Market: Home Healthcare and Remote Patient Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Wireless Patient Monitoring Devices Market: Long-Term Care and Senior Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Wireless Patient Monitoring Devices Market: Connectivity Technology Snapshot, 2025
TABLE 65: Segment Dashboard; Definition and Scope, by Connectivity Technology
TABLE 66: U.S. Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 67: U.S. Wireless Patient Monitoring Devices Market: Segment Share Analysis, by Connectivity Technology, 2025 & 2035 (%)
TABLE 68: U.S. Wireless Patient Monitoring Devices Market: Bluetooth and Bluetooth Low Energy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Wireless Patient Monitoring Devices Market: Wi-Fi-Enabled Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Wireless Patient Monitoring Devices Market: Cellular Connectivity Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Wireless Patient Monitoring Devices Market: Short-Range and Proprietary Wireless Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Wireless Patient Monitoring Devices Market: Hybrid and Multi-Connectivity Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Wireless Patient Monitoring Devices Market: Procurement and Deployment Model Snapshot, 2025
TABLE 74: Segment Dashboard; Definition and Scope, by Procurement and Deployment Model
TABLE 75: U.S. Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 76: U.S. Wireless Patient Monitoring Devices Market: Segment Share Analysis, by Procurement and Deployment Model, 2025 & 2035 (%)
TABLE 77: U.S. Wireless Patient Monitoring Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Wireless Patient Monitoring Devices Market: Integrated Delivery Network and Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Wireless Patient Monitoring Devices Market: Subscription and Device-as-a-Service Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Wireless Patient Monitoring Devices Market: Distributor, Specialty Supplier and DME Channel Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Wireless Patient Monitoring Devices Market: Virtual Care and Outsourced Remote Monitoring Partnerships Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Wireless Patient Monitoring Devices Market: Regional Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Region
TABLE 84: U.S. Wireless Patient Monitoring Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 85: U.S. Wireless Patient Monitoring Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 86: U.S. Wireless Patient Monitoring Devices Market: Regional Chronic Disease Burden and Monitoring Demand
TABLE 87: U.S. Wireless Patient Monitoring Devices Market: Regional Hospital, Home Health and Virtual Care Infrastructure
TABLE 88: West Region U.S. Wireless Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 89: West Region U.S. Wireless Patient Monitoring Devices Market: Key Manufacturers and Connected Care Ecosystem
TABLE 90: West Region U.S. Wireless Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 96: California Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 97: California Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 98: California Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: California Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 100: California Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 101: Washington Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 102: Washington Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Washington Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Washington Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 105: Washington Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 106: Arizona Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 107: Arizona Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Arizona Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Arizona Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 110: Arizona Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 111: Colorado Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 112: Colorado Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Colorado Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Colorado Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 115: Colorado Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 116: Oregon Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 117: Oregon Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 118: Oregon Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Oregon Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 120: Oregon Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 121: Utah Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 122: Utah Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Utah Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Utah Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 125: Utah Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 126: Nevada Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 127: Nevada Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: Nevada Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: Nevada Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 130: Nevada Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 131: New Mexico Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 132: New Mexico Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 136: Idaho Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 137: Idaho Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: Idaho Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Idaho Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 140: Idaho Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 141: Montana Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 142: Montana Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Montana Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Montana Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 145: Montana Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 146: Wyoming Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 147: Wyoming Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 151: Alaska Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 152: Alaska Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Alaska Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Alaska Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 155: Alaska Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 156: Hawaii Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 157: Hawaii Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Wireless Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 162: Northeast Region U.S. Wireless Patient Monitoring Devices Market: Key Manufacturers and Connected Care Ecosystem
TABLE 163: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 165: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 169: New York Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 170: New York Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 171: New York Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: New York Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 173: New York Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 174: Massachusetts Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 175: Massachusetts Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 179: New Jersey Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 180: New Jersey Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 184: Pennsylvania Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 185: Pennsylvania Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 189: Connecticut Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 190: Connecticut Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 194: Maine Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 195: Maine Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 196: Maine Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Maine Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 198: Maine Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 199: Vermont Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 200: Vermont Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: Vermont Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: Vermont Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 203: Vermont Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 204: New Hampshire Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 205: New Hampshire Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 209: Rhode Island Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 210: Rhode Island Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 214: Delaware Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 215: Delaware Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 216: Delaware Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 217: Delaware Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 218: Delaware Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Wireless Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 220: South Region U.S. Wireless Patient Monitoring Devices Market: Key Manufacturers and Connected Care Ecosystem
TABLE 221: South Region U.S. Wireless Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 227: Texas Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 228: Texas Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 229: Texas Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Texas Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 231: Texas Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 232: Florida Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 233: Florida Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 234: Florida Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Florida Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 236: Florida Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 237: Georgia Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 238: Georgia Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 239: Georgia Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: Georgia Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 241: Georgia Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 242: North Carolina Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 243: North Carolina Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 247: Tennessee Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 248: Tennessee Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 252: South Carolina Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 253: South Carolina Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 257: Alabama Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 258: Alabama Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 259: Alabama Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Alabama Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 261: Alabama Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 262: Mississippi Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 263: Mississippi Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 267: Louisiana Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 268: Louisiana Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 272: Arkansas Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 273: Arkansas Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 277: Kentucky Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 278: Kentucky Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 282: Oklahoma Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 283: Oklahoma Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 287: Virginia Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 288: Virginia Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 289: Virginia Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Virginia Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 291: Virginia Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 292: Maryland Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 293: Maryland Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 294: Maryland Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: Maryland Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 296: Maryland Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 297: West Virginia Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 298: West Virginia Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Wireless Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 303: Midwest Region U.S. Wireless Patient Monitoring Devices Market: Key Manufacturers and Connected Care Ecosystem
TABLE 304: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 310: Illinois Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 311: Illinois Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 312: Illinois Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Illinois Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 314: Illinois Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 315: Ohio Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 316: Ohio Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Ohio Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Ohio Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 319: Ohio Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 320: Michigan Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 321: Michigan Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 322: Michigan Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Michigan Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 324: Michigan Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 325: Minnesota Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 326: Minnesota Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 330: Indiana Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 331: Indiana Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 332: Indiana Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Indiana Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 334: Indiana Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 335: Wisconsin Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 336: Wisconsin Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 340: Missouri Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 341: Missouri Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 342: Missouri Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Missouri Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 344: Missouri Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 345: Iowa Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 346: Iowa Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 347: Iowa Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Iowa Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 349: Iowa Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 350: Kansas Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 351: Kansas Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 352: Kansas Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Kansas Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 354: Kansas Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 355: Nebraska Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 356: Nebraska Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 360: North Dakota Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 361: North Dakota Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 365: South Dakota Wireless Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 366: South Dakota Wireless Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Wireless Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Wireless Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Wireless Patient Monitoring Devices Market, by Procurement and Deployment Model, 2021–2035 (US$ Billion)
TABLE 370: U.S. Wireless Patient Monitoring Devices Market: Competitive Landscape Snapshot, 2025
TABLE 371: U.S. Wireless Patient Monitoring Devices Market: Key Company Market Share Analysis, 2025
TABLE 372: U.S. Wireless Patient Monitoring Devices Market: Company Positioning Matrix
TABLE 373: U.S. Wireless Patient Monitoring Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 374: U.S. Wireless Patient Monitoring Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 375: Philips: Company Profile
TABLE 376: GE HealthCare: Company Profile
TABLE 377: Medtronic: Company Profile
TABLE 378: Abbott Laboratories: Company Profile
TABLE 379: Masimo Corporation: Company Profile
TABLE 380: Baxter International: Company Profile
TABLE 381: Nihon Kohden Corporation: Company Profile
TABLE 382: Boston Scientific Corporation: Company Profile
TABLE 383: Dexcom: Company Profile
TABLE 384: Insulet Corporation: Company Profile
TABLE 385: iRhythm Technologies: Company Profile
TABLE 386: ZOLL Medical Corporation: Company Profile
TABLE 387: ResMed: Company Profile
TABLE 388: OMRON Healthcare: Company Profile
TABLE 389: AliveCor: Company Profile
TABLE 390: BioIntelliSense: Company Profile
TABLE 391: VivaLNK: Company Profile
TABLE 392: Current Health: Company Profile
TABLE 393: Health Recovery Solutions: Company Profile
TABLE 394: Spacelabs Healthcare: Company Profile
TABLE 395: Nonin Medical: Company Profile
TABLE 396: BIOTRONIK: Company Profile
TABLE 397: Sibel Health: Company Profile
TABLE 398: Empatica: Company Profile
TABLE 399: Withings Health Solutions: Company Profile
TABLE 400: U.S. Wireless Patient Monitoring Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 401: U.S. Wireless Patient Monitoring Devices Market: Disruptive Technologies Impact Matrix
TABLE 402: U.S. Wireless Patient Monitoring Devices Market: Emerging Business Trends
TABLE 403: U.S. Wireless Patient Monitoring Devices Market: Business Opportunities for Startups and Existing Players
TABLE 404: U.S. Wireless Patient Monitoring Devices Market: Investment Prioritization Matrix
TABLE 405: U.S. Wireless Patient Monitoring Devices Market: Future Reimbursement and Regulatory Scenarios
TABLE 406: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 407: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 408: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Physician Practices and Specialty Clinics
TABLE 409: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Home Healthcare and RPM Providers
TABLE 410: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 411: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for Distributors, GPOs and Channel Partners
TABLE 412: U.S. Wireless Patient Monitoring Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 413: U.S. Wireless Patient Monitoring Devices Market: Go-to-Market Strategy Considerations
TABLE 414: U.S. Wireless Patient Monitoring Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 415: U.S. Wireless Patient Monitoring Devices Market: Reimbursement and Evidence-Generation Strategy
TABLE 416: U.S. Wireless Patient Monitoring Devices Market: Cybersecurity, Interoperability and Data Governance Priorities
TABLE 417: U.S. Wireless Patient Monitoring Devices Market: State and Regional Market Entry Prioritization
TABLE 418: U.S. Wireless Patient Monitoring Devices Market: Scope Limitation
TABLE 419: U.S. Wireless Patient Monitoring Devices Market: Data Use Limitation
TABLE 420: U.S. Wireless Patient Monitoring Devices Market: Forecasting Limitation
TABLE 421: U.S. Wireless Patient Monitoring Devices Market: Legal Disclaimer
TABLE 422: U.S. Wireless Patient Monitoring Devices Market: Third-Party Data Disclaimer
TABLE 423: U.S. Wireless Patient Monitoring Devices Market: Medical and Clinical Decision Disclaimer
TABLE 424: U.S. Wireless Patient Monitoring Devices Market: Regulatory and Reimbursement Change Disclaimer

List of Figures

FIGURE 1: U.S. Wireless Patient Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Wireless Patient Monitoring Devices Market: Market Ecosystem
FIGURE 4: U.S. Wireless Patient Monitoring Devices Market: Stakeholder Ecosystem
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: Year-wise Market Growth Curve, 2021–2035
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital and Health System Procurement Decision Framework
FIGURE 13: Remote Monitoring Program Return-on-Investment Framework
FIGURE 14: PESTEL Analysis
FIGURE 15: Porter’s Five Forces Analysis
FIGURE 16: Value Chain Analysis
FIGURE 17: Supply Chain Analysis
FIGURE 18: Digitalization, Cloud Connectivity and AI-Based Clinical Triage Impact
FIGURE 19: FDA, Reimbursement, Cybersecurity and Interoperability Landscape
FIGURE 20: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 21: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Wireless Cardiac Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Wireless Blood Pressure Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Wireless Blood Glucose Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Wireless Respiratory and Oxygen Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Wireless Multiparameter and Other Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Cardiovascular Disease and Arrhythmia Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Diabetes and Metabolic Disease Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Respiratory and Sleep Disorder Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Acute, Critical and Post-Acute Care Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Home-Based and Preventive Health Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 35: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Physician Practices and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Ambulatory, Emergency and Post-Acute Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Home Healthcare and Remote Patient Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Long-Term Care and Senior Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Connectivity Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 42: Connectivity Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Bluetooth and Bluetooth Low Energy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Wi-Fi-Enabled Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Cellular Connectivity Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Short-Range and Proprietary Wireless Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Hybrid and Multi-Connectivity Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Procurement and Deployment Model Segment Market Share Analysis, 2025 & 2035
FIGURE 49: Procurement and Deployment Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Integrated Delivery Network and Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Subscription and Device-as-a-Service Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Distributor, Specialty Supplier and DME Channel Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Virtual Care and Outsourced Remote Monitoring Partnerships Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Chronic Disease Burden, Digital Access and Monitoring Adoption Map
FIGURE 58: West Region U.S. Wireless Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Washington Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Arizona Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Colorado Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Oregon Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Utah Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Nevada Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Mexico Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Idaho Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Montana Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Wyoming Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Alaska Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hawaii Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Northeast Region U.S. Wireless Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Massachusetts Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Jersey Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Pennsylvania Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Connecticut Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Maine Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Vermont Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: New Hampshire Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Rhode Island Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Delaware Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: South Region U.S. Wireless Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Florida Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Georgia Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: North Carolina Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Tennessee Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: South Carolina Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Alabama Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Mississippi Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Louisiana Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Arkansas Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Kentucky Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Oklahoma Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Virginia Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Maryland Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: West Virginia Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Midwest Region U.S. Wireless Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 106: Midwest Region Market Share Analysis by State, 2025
FIGURE 107: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Illinois Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Ohio Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Michigan Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Minnesota Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Indiana Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Wisconsin Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Missouri Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Iowa Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Kansas Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Nebraska Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: North Dakota Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: South Dakota Wireless Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Company Positioning Matrix
FIGURE 122: Key Player Product Portfolio Benchmarking
FIGURE 123: Connectivity, Interoperability and Clinical Evidence Benchmarking
FIGURE 124: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 125: Wireless Patient Monitoring Device Innovation Roadmap
FIGURE 126: AI-Assisted Predictive Monitoring Adoption Roadmap
FIGURE 127: Multi-Parameter Wearable Biosensor Opportunity Map
FIGURE 128: Cellular-First and 5G Monitoring Growth Roadmap
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Strategic Growth Roadmap for U.S. Wireless Patient Monitoring Device Companies
FIGURE 134: Go-to-Market Strategy Framework
FIGURE 135: Product Positioning and Portfolio Expansion Framework
FIGURE 136: Reimbursement and Evidence-Generation Strategy Framework
FIGURE 137: State and Regional Market Entry Prioritization Map
FIGURE 138: Report Scope and Disclaimer Framework